Braveheart Bio Statistics
NASDAQ: BRVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
20.39+1.12 (+5.81%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Braveheart Bio by the numbers
Braveheart Bio has a market capitalization of $1.67 billion based on 82.07M shares outstanding. With trailing EPS of $-6.59, Braveheart Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.9% below its 50-day average and 12.6% below its 200-day average.
Average daily trading volume is 491.27K shares, or about $10.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BRVE valuation vs. peer median
| Metric | BRVE | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.67B | $1.72B | -2% |
| Avg. volume | 491.27K | 922.18K | -47% |
Peer median across 8 companies: RARE, AGIO, KRSA, SDGR, ZBIO, TRAX, STOK, ETON.
Valuation
- Market cap
- $1.67B
- EPS (TTM)
- $-6.59
- Shares outstanding
- 82.07M
Price and trading
- Previous close
- 19.27
- Open
- 19.29
- Day range
- 18.83 – 21.11
- 52-week range
- 16.70 – 32.00
- Beta
- —
- Volume
- 866.73K
- Average volume
- 491.27K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Dec 8, 2026
Additional statistics
- Market Cap
- 1.67B
- Forward Pe
- -10.25
- Eps
- -6.59
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 32.00
- Week52 Low
- 16.70
- Avg Volume
- 491.27K
- Shares Outstanding
- 82.07M
- Ma50
- 21.23
- Ma200
- 23.33
- Earnings Date
- Dec 8, 2026
- Pct From52w High
- -36.28%
- Pct From52w Low
- 22.10%